Alimera Sciences, Inc. (ALIM) recently announced that it has entered into a definitive agreement with Minnesota-based biopharmaceutical company, ANI Pharmaceuticals, Inc. (ANIP) , wherein the latter has agreed to acquire Alimera. Shares of Alimera shot up 75.9% on Jun 24 following the news announcement, while ANIP shares rose 7.3%. Per the deal terms, Alimera is set to be acquired by ANIP for $5.50 per share in cash and its investors will be entitled to a contingent value right for up to$0.50 per share if ...